Insights from 2023 ESMO Annual Meeting


 

ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpelisib, in ER+/HER2- Advanced BC"

0 views
December 1, 2023
Comments 0
Login to view comments. Click here to Login